In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct trials transplanting genetically-modifie ...

The FDA has set a goal date of Aug. 27, 2025. If approved, the therapy would be branded as Lytenava and be the first ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

Newswatch 16's Kerry Kearns spoke with a medical expert about why you should become a donor in this Healthwatch 16.

The reductions come as the federal government has asked other companies to do some of UNOS' work and as the federal Department of Health and Human Services has been told ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...

Linda Valenzano of Ocean Township was thrilled she could help a South Jersey man by giving him her late brother's kidney.

Home > Press release: The 2025 Else Kröner Fresenius Prize for ...

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) and Creative Medical Technology (NASDAQ:CELZ – Get Free Report) are both small-cap medical companies, but which is the better business? We will ...

John Beeler, Ph.D., SVP of Business Development at BPGbio, brings over two decades of experience in biotechnology and ...

Tennessee has become the fourth state to prohibit insurance companies from funding organ transplants if the body parts come ...

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...